ArticleClinical rheumatology2024

Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.

Marta Novella-Navarro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.